Tissue-Engineered Breast Reconstruction with Brava-Assisted Fat Grafting
Authors:
- Roger K. KhouriRKRoger K. Khouri
- Gino RigottiGRGino Rigotti
- Eufemiano CardosoECEufemiano Cardoso
- Alessandra MarchiAMAlessandra Marchi
- Silvia C. RotembergSRSilvia C. Rotemberg
- Thomas J. BakerTBThomas J. Baker
- Thomas M. BiggsTBThomas M. Biggs
Top Cited Papers
- 1 March 2015
- journal article
- research article
- Published by Wolters Kluwer Health in Plastic and Reconstructive Surgery
- Vol. 135 (3) , 643-658
Abstract
The ability of autologous fat transfer to reconstruct an entire breast is not established. The authors harnessed the regenerative capabilities of external expansion and autologous fat transfer to completely reconstruct breasts. The authors performed 1877 Brava plus autologous fat transfer procedures on 616 breasts in 488 women to reconstruct 99 lumpectomies, 87 immediate breast reconstructions, and 430 delayed total breast reconstructions. After 2 to 4 weeks of Brava expansion, which increased volume by 100 to 300 percent, the authors diffusely grafted the breasts with 100 to 400 ml (225 ml average) of 15 g-sedimented, manually harvested lipoaspirate. The procedure was repeated every 8 to 14 weeks until completion. The authors compared costs of this reconstruction with established deep inferior epigastric artery perforator/transverse rectus abdominis musculocutaneous flaps and implant procedures. Follow-up ranged from 6 months to 7 years (mean, 2.5 years), with 0.5 percent locoregional recurrence. Four hundred twenty-seven women completed the reconstruction, whereas 12.5 percent dropped out (2.5 percent medical, 10 percent personal reasons). Completion required 2.7 procedures for nonirradiated and 4.8 procedures for irradiated mastectomies. Patients recovered soft, natural appearing breasts with nearly normal sensation. Complications included five pneumothoraces and 20 ulcerative infections. Radiographically recognized benign palpable masses were observed in 12 percent of nonirradiated and 37 percent of irradiated breasts. The cost of Brava plus autologous fat transfer is 47 percent and 66 percent that of current reconstruction alternatives. Brava plus autologous fat transfer is a minimally invasive, incisionless, safe, economic, and effective alternative for breast reconstruction. Therapeutic, IV.Keywords
This publication has 48 references indexed in Scilit:
- Aesthetic Applications of Brava-Assisted Megavolume Fat Grafting to the BreastsPlastic and Reconstructive Surgery, 2014
- Megavolume Autologous Fat TransferPlastic and Reconstructive Surgery, 2014
- Mechanisms of Action of External Volume Expansion DevicesPlastic and Reconstructive Surgery, 2013
- A Paradigm Shift in U.S. Breast ReconstructionPlastic and Reconstructive Surgery, 2013
- External Volume Expansion Increases Subcutaneous Thickness, Cell Proliferation, and Vascular Remodeling in a Murine ModelPlastic and Reconstructive Surgery, 2012
- Brava and Autologous Fat Transfer Is a Safe and Effective Breast Augmentation AlternativePlastic and Reconstructive Surgery, 2012
- Enhancement of Surface Wettability via the Modification of Microtextured Titanium Implant Surfaces with PolyelectrolytesLangmuir, 2011
- Scaffolds for Tissue Engineering and 3D Cell Culture2010
- In Vivo Acceleration of Skin Growth Using a Servo-Controlled Stretching DeviceTissue Engineering Part C: Methods, 2009
- Micro-mechanical forces as a potent stimulator of wound healingJournal of the American College of Surgeons, 2004